

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.60688804 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.60688804 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.60688804 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.60688804 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.60688804 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.60688804 |
| 7 | microglial cell activation (GO:0001774) | 4.87545299 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.63631782 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.42865357 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.31937803 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.22232164 |
| 12 | response to pheromone (GO:0019236) | 4.14207108 |
| 13 | regulation of hippo signaling (GO:0035330) | 4.12375657 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.10947582 |
| 15 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.00860829 |
| 16 | glycosphingolipid catabolic process (GO:0046479) | 3.96400753 |
| 17 | prostate gland growth (GO:0060736) | 3.85019652 |
| 18 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.72746425 |
| 19 | oligosaccharide catabolic process (GO:0009313) | 3.70318865 |
| 20 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.69911585 |
| 21 | detection of light stimulus involved in visual perception (GO:0050908) | 3.69911585 |
| 22 | macrophage activation (GO:0042116) | 3.69668335 |
| 23 | respiratory burst (GO:0045730) | 3.67947173 |
| 24 | sphingoid metabolic process (GO:0046519) | 3.67035817 |
| 25 | response to host immune response (GO:0052572) | 3.66826001 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.66826001 |
| 27 | diol metabolic process (GO:0034311) | 3.64324700 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.57649033 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.57649033 |
| 30 | myeloid cell activation involved in immune response (GO:0002275) | 3.57442980 |
| 31 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.55535410 |
| 32 | cellular response to ATP (GO:0071318) | 3.54776766 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.50438944 |
| 34 | activated T cell proliferation (GO:0050798) | 3.49486036 |
| 35 | glycolipid catabolic process (GO:0019377) | 3.47564826 |
| 36 | multicellular organism reproduction (GO:0032504) | 3.46819086 |
| 37 | phagosome maturation (GO:0090382) | 3.45984307 |
| 38 | ceramide catabolic process (GO:0046514) | 3.44275166 |
| 39 | regulation of establishment of cell polarity (GO:2000114) | 3.41813661 |
| 40 | neutrophil activation (GO:0042119) | 3.39877350 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.36026204 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 3.36026204 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 3.36026204 |
| 44 | sphingosine metabolic process (GO:0006670) | 3.34735358 |
| 45 | limb bud formation (GO:0060174) | 3.33436610 |
| 46 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.30599919 |
| 47 | granulocyte activation (GO:0036230) | 3.29535049 |
| 48 | response to peptidoglycan (GO:0032494) | 3.23797543 |
| 49 | cellular extravasation (GO:0045123) | 3.23545141 |
| 50 | superoxide anion generation (GO:0042554) | 3.23420341 |
| 51 | response to host (GO:0075136) | 3.21504298 |
| 52 | response to host defenses (GO:0052200) | 3.21504298 |
| 53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21504298 |
| 54 | positive regulation of heat generation (GO:0031652) | 3.20890083 |
| 55 | platelet dense granule organization (GO:0060155) | 3.14938840 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.14513207 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.12908789 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10850410 |
| 59 | ovulation from ovarian follicle (GO:0001542) | 3.10811603 |
| 60 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.09168788 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08987303 |
| 62 | mast cell activation (GO:0045576) | 3.08742094 |
| 63 | behavioral response to nicotine (GO:0035095) | 3.06553989 |
| 64 | negative regulation of interleukin-17 production (GO:0032700) | 3.05099075 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 3.04758419 |
| 66 | G-protein coupled receptor internalization (GO:0002031) | 3.03562420 |
| 67 | positive regulation of mast cell degranulation (GO:0043306) | 3.02659217 |
| 68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02659217 |
| 69 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.01771825 |
| 70 | regulation of mast cell activation (GO:0033003) | 3.01738118 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 3.01239084 |
| 72 | regulation of antigen processing and presentation (GO:0002577) | 2.98875086 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98694473 |
| 74 | cellular ketone body metabolic process (GO:0046950) | 2.93947253 |
| 75 | L-amino acid import (GO:0043092) | 2.93709434 |
| 76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92874479 |
| 77 | I-kappaB phosphorylation (GO:0007252) | 2.92302797 |
| 78 | neutrophil mediated immunity (GO:0002446) | 2.91003943 |
| 79 | myeloid dendritic cell differentiation (GO:0043011) | 2.89880205 |
| 80 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.89288330 |
| 81 | kynurenine metabolic process (GO:0070189) | 2.89248353 |
| 82 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.88945638 |
| 83 | myeloid leukocyte activation (GO:0002274) | 2.86872032 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86309857 |
| 85 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.85394609 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 2.82943675 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.82896257 |
| 88 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.82109633 |
| 89 | NAD biosynthetic process (GO:0009435) | 2.82023220 |
| 90 | long term synaptic depression (GO:0060292) | 2.80177319 |
| 91 | startle response (GO:0001964) | 2.79716706 |
| 92 | coenzyme catabolic process (GO:0009109) | 2.79611336 |
| 93 | ketone body metabolic process (GO:1902224) | 2.77678511 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.77166610 |
| 95 | reflex (GO:0060004) | 2.77015910 |
| 96 | mature B cell differentiation (GO:0002335) | 2.73589428 |
| 97 | negative regulation of mast cell activation (GO:0033004) | 2.72791643 |
| 98 | regulation of respiratory system process (GO:0044065) | 2.72698934 |
| 99 | cardiac right ventricle morphogenesis (GO:0003215) | 2.72009071 |
| 100 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.71611683 |
| 101 | regulation of acrosome reaction (GO:0060046) | 2.70933647 |
| 102 | nitric oxide biosynthetic process (GO:0006809) | 2.70583704 |
| 103 | mast cell degranulation (GO:0043303) | 2.70365301 |
| 104 | mast cell activation involved in immune response (GO:0002279) | 2.70365301 |
| 105 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.70201064 |
| 106 | locomotory exploration behavior (GO:0035641) | 2.69809233 |
| 107 | neuron cell-cell adhesion (GO:0007158) | 2.69540535 |
| 108 | epithelial cell maturation (GO:0002070) | 2.69131245 |
| 109 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.68436552 |
| 110 | regulation of heat generation (GO:0031650) | 2.65716560 |
| 111 | lysosome organization (GO:0007040) | 2.65683942 |
| 112 | lytic vacuole organization (GO:0080171) | 2.65683942 |
| 113 | cornea development in camera-type eye (GO:0061303) | 2.65446301 |
| 114 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.64812240 |
| 115 | purinergic receptor signaling pathway (GO:0035587) | 2.64760666 |
| 116 | defense response to protozoan (GO:0042832) | 2.63642868 |
| 117 | regulation of interferon-alpha production (GO:0032647) | 2.63406262 |
| 118 | regulation of B cell differentiation (GO:0045577) | 2.62739026 |
| 119 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.61860836 |
| 120 | histone H3-K9 methylation (GO:0051567) | 2.61484817 |
| 121 | positive regulation of B cell differentiation (GO:0045579) | 2.60361353 |
| 122 | germinal center formation (GO:0002467) | 2.59351326 |
| 123 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.58721891 |
| 124 | amino acid import (GO:0043090) | 2.58205842 |
| 125 | indolalkylamine metabolic process (GO:0006586) | 2.58046869 |
| 126 | B cell receptor signaling pathway (GO:0050853) | 2.57381982 |
| 127 | adenosine receptor signaling pathway (GO:0001973) | 2.56634073 |
| 128 | sympathetic nervous system development (GO:0048485) | 2.56301223 |
| 129 | sphingolipid catabolic process (GO:0030149) | 2.54526485 |
| 130 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.52913739 |
| 131 | pseudouridine synthesis (GO:0001522) | 2.51784841 |
| 132 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.51622275 |
| 133 | positive regulation of prostaglandin secretion (GO:0032308) | 2.50922561 |
| 134 | actin filament polymerization (GO:0030041) | 2.50910627 |
| 135 | sperm motility (GO:0030317) | 2.49730841 |
| 136 | detection of molecule of bacterial origin (GO:0032490) | 2.48303411 |
| 137 | central nervous system neuron axonogenesis (GO:0021955) | 2.47899189 |
| 138 | leukocyte degranulation (GO:0043299) | 2.45324034 |
| 139 | tryptophan metabolic process (GO:0006568) | 2.44951750 |
| 140 | Golgi to endosome transport (GO:0006895) | 2.44446589 |
| 141 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.43666752 |
| 142 | ganglioside metabolic process (GO:0001573) | 2.43467202 |
| 143 | regulation of platelet aggregation (GO:0090330) | 2.43380768 |
| 144 | transferrin transport (GO:0033572) | 2.42437934 |
| 145 | postsynaptic membrane organization (GO:0001941) | 2.41504328 |
| 146 | regulation of regulated secretory pathway (GO:1903305) | 2.41434338 |
| 147 | signal peptide processing (GO:0006465) | 2.41323085 |
| 148 | auditory receptor cell stereocilium organization (GO:0060088) | 2.41214362 |
| 149 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.40851146 |
| 150 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.40851146 |
| 151 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.40851146 |
| 152 | dendritic cell differentiation (GO:0097028) | 2.40778958 |
| 153 | fucose catabolic process (GO:0019317) | 2.40190809 |
| 154 | L-fucose metabolic process (GO:0042354) | 2.40190809 |
| 155 | L-fucose catabolic process (GO:0042355) | 2.40190809 |
| 156 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.39945216 |
| 157 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.39087672 |
| 158 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.38380065 |
| 159 | regulation of ruffle assembly (GO:1900027) | 2.37842373 |
| 160 | monocyte chemotaxis (GO:0002548) | 2.36505934 |
| 161 | neuronal action potential (GO:0019228) | 2.36210264 |
| 162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.35965786 |
| 163 | transmission of nerve impulse (GO:0019226) | 2.35664514 |
| 164 | DNA methylation involved in gamete generation (GO:0043046) | 2.35188684 |
| 165 | neutrophil chemotaxis (GO:0030593) | 2.34478186 |
| 166 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.34451375 |
| 167 | phagocytosis, engulfment (GO:0006911) | 2.33899515 |
| 168 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.32691872 |
| 169 | piRNA metabolic process (GO:0034587) | 2.31933805 |
| 170 | glutamate receptor signaling pathway (GO:0007215) | 2.30661106 |
| 171 | alanine transport (GO:0032328) | 2.30259934 |
| 172 | acrosome reaction (GO:0007340) | 2.27882864 |
| 173 | pigment cell differentiation (GO:0050931) | 2.27532797 |
| 174 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.27373309 |
| 175 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.27200642 |
| 176 | glycerophospholipid catabolic process (GO:0046475) | 2.26048563 |
| 177 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.25608369 |
| 178 | phasic smooth muscle contraction (GO:0014821) | 2.25347475 |
| 179 | basic amino acid transport (GO:0015802) | 2.24727940 |
| 180 | fatty acid transmembrane transport (GO:1902001) | 2.23264858 |
| 181 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.21296132 |
| 182 | photoreceptor cell maintenance (GO:0045494) | 2.20294294 |
| 183 | spinal cord motor neuron differentiation (GO:0021522) | 2.20021771 |
| 184 | rhodopsin mediated signaling pathway (GO:0016056) | 2.19835350 |
| 185 | nucleotide transmembrane transport (GO:1901679) | 2.19668920 |
| 186 | amine catabolic process (GO:0009310) | 2.18427433 |
| 187 | cellular biogenic amine catabolic process (GO:0042402) | 2.18427433 |
| 188 | regulation of Rab GTPase activity (GO:0032313) | 2.18074265 |
| 189 | positive regulation of Rab GTPase activity (GO:0032851) | 2.18074265 |
| 190 | establishment of protein localization to Golgi (GO:0072600) | 2.17976966 |
| 191 | reproduction (GO:0000003) | 2.17575277 |
| 192 | carnitine transport (GO:0015879) | 2.17288931 |
| 193 | amino-acid betaine transport (GO:0015838) | 2.17288931 |
| 194 | positive regulation of meiosis (GO:0045836) | 2.17268742 |
| 195 | negative regulation of organelle assembly (GO:1902116) | 2.17243916 |
| 196 | regulation of female receptivity (GO:0045924) | 2.17165554 |
| 197 | indole-containing compound metabolic process (GO:0042430) | 2.16446829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.17455461 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.30725417 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.13072752 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.40264556 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.30827473 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10400138 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.85403391 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.76003473 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65976165 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.64481337 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.63370321 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.56577451 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.45390027 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.43318168 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.36676309 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30750801 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.19879756 |
| 18 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 2.12956636 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10858783 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08184291 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99663010 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.89039582 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87962226 |
| 24 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.87709099 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86077501 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86026974 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85714244 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.84997805 |
| 29 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81381015 |
| 30 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.81381015 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.80210926 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79993294 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71705138 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.71370625 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70199865 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.68441334 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65520946 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65220726 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63721027 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62423892 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62008151 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59385378 |
| 43 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.58519206 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58425340 |
| 45 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.57903574 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56982211 |
| 47 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53076852 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51409155 |
| 49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51409155 |
| 50 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.51365235 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50212287 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49504540 |
| 53 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.43026262 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42731678 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.42583022 |
| 56 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.42061363 |
| 57 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40412369 |
| 58 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.39604397 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38656376 |
| 60 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37306823 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.35234013 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34802918 |
| 63 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.33995574 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33317349 |
| 65 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.31973795 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.31973795 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31487810 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31255687 |
| 69 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.30807733 |
| 70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29803377 |
| 71 | RXR_22108803_ChIP-Seq_LS180_Human | 1.28933254 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28277978 |
| 73 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27957173 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25955941 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23705972 |
| 76 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.23292776 |
| 77 | EWS_26573619_Chip-Seq_HEK293_Human | 1.22787514 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22576322 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20572814 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19812620 |
| 81 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19666367 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18917798 |
| 83 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17270014 |
| 84 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16940604 |
| 85 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16076941 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14882584 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.14492674 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14063056 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12711213 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12540812 |
| 91 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12202179 |
| 92 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11441762 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11359394 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11233950 |
| 95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10795980 |
| 96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10284052 |
| 97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10265705 |
| 98 | ERA_21632823_ChIP-Seq_H3396_Human | 1.10056551 |
| 99 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09591395 |
| 100 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09494422 |
| 101 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09439098 |
| 102 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09246620 |
| 103 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06843785 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05764209 |
| 105 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05764209 |
| 106 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05585607 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05485927 |
| 108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05107139 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04788603 |
| 110 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04644933 |
| 111 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04362434 |
| 112 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.03403280 |
| 113 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02958424 |
| 114 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02732262 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02518349 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01685873 |
| 117 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01286878 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00541594 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00529212 |
| 120 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00528242 |
| 121 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00527530 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99879696 |
| 123 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99811536 |
| 124 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99747605 |
| 125 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99651558 |
| 126 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99564722 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99373278 |
| 128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97861476 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97548081 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96931750 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95166139 |
| 132 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94912233 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94677122 |
| 134 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93935564 |
| 135 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93043738 |
| 136 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92896695 |
| 137 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.92511824 |
| 138 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92296636 |
| 139 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90859427 |
| 140 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90858850 |
| 141 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90820276 |
| 142 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90795579 |
| 143 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90394668 |
| 144 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89798315 |
| 145 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89552352 |
| 146 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89552352 |
| 147 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88884325 |
| 148 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88483942 |
| 149 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.87598224 |
| 150 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87550422 |
| 151 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87382435 |
| 152 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.87324283 |
| 153 | NCOR_22424771_ChIP-Seq_293T_Human | 0.87216437 |
| 154 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.87026745 |
| 155 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.86533470 |
| 156 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86375390 |
| 157 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85769920 |
| 158 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85542445 |
| 159 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.85313649 |
| 160 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85238739 |
| 161 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.85135051 |
| 162 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.84640875 |
| 163 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83585134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 6.15359820 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.89885578 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.61204310 |
| 4 | MP0000427_abnormal_hair_cycle | 3.42550550 |
| 5 | MP0004510_myositis | 3.41643059 |
| 6 | MP0003136_yellow_coat_color | 3.39628067 |
| 7 | MP0003880_abnormal_central_pattern | 3.01860684 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.00294483 |
| 9 | MP0006082_CNS_inflammation | 2.71410075 |
| 10 | MP0003303_peritoneal_inflammation | 2.69639080 |
| 11 | MP0002419_abnormal_innate_immunity | 2.67243636 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.59430280 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.55952955 |
| 14 | MP0003436_decreased_susceptibility_to | 2.49416063 |
| 15 | MP0003195_calcinosis | 2.48622338 |
| 16 | MP0001790_abnormal_immune_system | 2.45422077 |
| 17 | MP0005387_immune_system_phenotype | 2.45422077 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.42199736 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.29790606 |
| 20 | MP0005174_abnormal_tail_pigmentation | 2.27135087 |
| 21 | MP0005248_abnormal_Harderian_gland | 2.25155169 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 2.23109618 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.21145457 |
| 24 | MP0005671_abnormal_response_to | 2.15103528 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.14774284 |
| 26 | MP0001800_abnormal_humoral_immune | 2.07374200 |
| 27 | MP0000372_irregular_coat_pigmentation | 2.07237868 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 2.04296224 |
| 29 | MP0002723_abnormal_immune_serum | 1.99574153 |
| 30 | MP0005310_abnormal_salivary_gland | 1.98663850 |
| 31 | MP0005257_abnormal_intraocular_pressure | 1.98199397 |
| 32 | MP0001919_abnormal_reproductive_system | 1.96959615 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.95161372 |
| 34 | MP0005025_abnormal_response_to | 1.94803646 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.93946542 |
| 36 | MP0003690_abnormal_glial_cell | 1.89084171 |
| 37 | MP0004381_abnormal_hair_follicle | 1.86175876 |
| 38 | MP0005410_abnormal_fertilization | 1.84201834 |
| 39 | MP0004742_abnormal_vestibular_system | 1.82965621 |
| 40 | MP0001819_abnormal_immune_cell | 1.81008254 |
| 41 | MP0000685_abnormal_immune_system | 1.79933702 |
| 42 | MP0000538_abnormal_urinary_bladder | 1.78781651 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.78655403 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.78116192 |
| 45 | MP0000383_abnormal_hair_follicle | 1.76723342 |
| 46 | MP0009745_abnormal_behavioral_response | 1.76335617 |
| 47 | MP0000371_diluted_coat_color | 1.71632162 |
| 48 | MP0002064_seizures | 1.68252379 |
| 49 | MP0000604_amyloidosis | 1.67657021 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.66340552 |
| 51 | MP0002736_abnormal_nociception_after | 1.62360587 |
| 52 | MP0001968_abnormal_touch/_nociception | 1.60613826 |
| 53 | MP0009785_altered_susceptibility_to | 1.59940959 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.59904938 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.59606737 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 1.58551592 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.56246167 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.54752076 |
| 59 | MP0003724_increased_susceptibility_to | 1.54144256 |
| 60 | MP0006276_abnormal_autonomic_nervous | 1.53100382 |
| 61 | MP0003075_altered_response_to | 1.52522436 |
| 62 | MP0009046_muscle_twitch | 1.50593013 |
| 63 | MP0002405_respiratory_system_inflammati | 1.47724013 |
| 64 | MP0001501_abnormal_sleep_pattern | 1.47689778 |
| 65 | MP0008872_abnormal_physiological_respon | 1.40920560 |
| 66 | MP0001853_heart_inflammation | 1.40748176 |
| 67 | MP0001486_abnormal_startle_reflex | 1.39213848 |
| 68 | MP0005409_darkened_coat_color | 1.36988471 |
| 69 | MP0002837_dystrophic_cardiac_calcinosis | 1.36868491 |
| 70 | MP0002090_abnormal_vision | 1.36057443 |
| 71 | MP0002735_abnormal_chemical_nociception | 1.35636352 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.35062131 |
| 73 | MP0002572_abnormal_emotion/affect_behav | 1.33106205 |
| 74 | MP0000920_abnormal_myelination | 1.32961812 |
| 75 | MP0005253_abnormal_eye_physiology | 1.31512947 |
| 76 | MP0005423_abnormal_somatic_nervous | 1.29279375 |
| 77 | MP0002063_abnormal_learning/memory/cond | 1.28661664 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.28258924 |
| 79 | MP0005389_reproductive_system_phenotype | 1.26198559 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.25026176 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 1.22607948 |
| 82 | MP0002102_abnormal_ear_morphology | 1.22018474 |
| 83 | MP0002693_abnormal_pancreas_physiology | 1.21518675 |
| 84 | MP0001851_eye_inflammation | 1.20839042 |
| 85 | MP0001881_abnormal_mammary_gland | 1.20281452 |
| 86 | MP0000716_abnormal_immune_system | 1.18577011 |
| 87 | MP0001664_abnormal_digestion | 1.17446884 |
| 88 | MP0000343_altered_response_to | 1.14360223 |
| 89 | MP0001440_abnormal_grooming_behavior | 1.11825894 |
| 90 | MP0010386_abnormal_urinary_bladder | 1.11786252 |
| 91 | MP0001845_abnormal_inflammatory_respons | 1.11179670 |
| 92 | MP0000681_abnormal_thyroid_gland | 1.09949816 |
| 93 | MP0003191_abnormal_cellular_cholesterol | 1.09844043 |
| 94 | MP0005166_decreased_susceptibility_to | 1.09053475 |
| 95 | MP0008877_abnormal_DNA_methylation | 1.09048657 |
| 96 | MP0003936_abnormal_reproductive_system | 1.08443545 |
| 97 | MP0003448_altered_tumor_morphology | 1.06719250 |
| 98 | MP0002229_neurodegeneration | 1.06119413 |
| 99 | MP0003329_amyloid_beta_deposits | 1.05420314 |
| 100 | MP0002098_abnormal_vibrissa_morphology | 1.04179716 |
| 101 | MP0002067_abnormal_sensory_capabilities | 1.03003245 |
| 102 | MP0002398_abnormal_bone_marrow | 1.02745818 |
| 103 | MP0003300_gastrointestinal_ulcer | 1.01958648 |
| 104 | MP0002272_abnormal_nervous_system | 1.01534629 |
| 105 | MP0001756_abnormal_urination | 1.00932846 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.99139417 |
| 107 | MP0001873_stomach_inflammation | 0.98615103 |
| 108 | MP0000689_abnormal_spleen_morphology | 0.97432850 |
| 109 | MP0003828_pulmonary_edema | 0.96688623 |
| 110 | MP0004043_abnormal_pH_regulation | 0.96138588 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.95619927 |
| 112 | MP0005408_hypopigmentation | 0.94150712 |
| 113 | MP0002168_other_aberrant_phenotype | 0.93704243 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 0.93003800 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.92385828 |
| 116 | MP0008260_abnormal_autophagy | 0.92037279 |
| 117 | MP0008469_abnormal_protein_level | 0.92021884 |
| 118 | MP0002751_abnormal_autonomic_nervous | 0.91063082 |
| 119 | MP0003787_abnormal_imprinting | 0.88805572 |
| 120 | MP0004885_abnormal_endolymph | 0.87397942 |
| 121 | MP0001970_abnormal_pain_threshold | 0.86297444 |
| 122 | MP0002095_abnormal_skin_pigmentation | 0.85702148 |
| 123 | MP0009764_decreased_sensitivity_to | 0.84301164 |
| 124 | MP0000627_abnormal_mammary_gland | 0.83048565 |
| 125 | MP0010155_abnormal_intestine_physiology | 0.82425428 |
| 126 | MP0009333_abnormal_splenocyte_physiolog | 0.82405884 |
| 127 | MP0002734_abnormal_mechanical_nocicepti | 0.82195802 |
| 128 | MP0009278_abnormal_bone_marrow | 0.81619460 |
| 129 | MP0002653_abnormal_ependyma_morphology | 0.81544329 |
| 130 | MP0002722_abnormal_immune_system | 0.80305592 |
| 131 | MP0002138_abnormal_hepatobiliary_system | 0.80284536 |
| 132 | MP0002429_abnormal_blood_cell | 0.80071194 |
| 133 | MP0002075_abnormal_coat/hair_pigmentati | 0.79699278 |
| 134 | MP0001188_hyperpigmentation | 0.79483768 |
| 135 | MP0002557_abnormal_social/conspecific_i | 0.78592572 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.78397757 |
| 137 | MP0003634_abnormal_glial_cell | 0.78207656 |
| 138 | MP0002733_abnormal_thermal_nociception | 0.77661594 |
| 139 | MP0000470_abnormal_stomach_morphology | 0.77055447 |
| 140 | MP0001944_abnormal_pancreas_morphology | 0.76343348 |
| 141 | MP0003698_abnormal_male_reproductive | 0.74178170 |
| 142 | MP0004924_abnormal_behavior | 0.73950396 |
| 143 | MP0005386_behavior/neurological_phenoty | 0.73950396 |
| 144 | MP0003633_abnormal_nervous_system | 0.73938822 |
| 145 | MP0002184_abnormal_innervation | 0.73926602 |
| 146 | MP0005367_renal/urinary_system_phenotyp | 0.72434552 |
| 147 | MP0000516_abnormal_urinary_system | 0.72434552 |
| 148 | MP0002933_joint_inflammation | 0.71730590 |
| 149 | MP0005171_absent_coat_pigmentation | 0.71455929 |
| 150 | MP0003866_abnormal_defecation | 0.71083345 |
| 151 | MP0004147_increased_porphyrin_level | 0.71001155 |
| 152 | MP0009384_cardiac_valve_regurgitation | 0.70881209 |
| 153 | MP0001529_abnormal_vocalization | 0.69844938 |
| 154 | MP0004883_abnormal_blood_vessel | 0.69565593 |
| 155 | MP0003879_abnormal_hair_cell | 0.69426815 |
| 156 | MP0002277_abnormal_respiratory_mucosa | 0.69184193 |
| 157 | MP0003950_abnormal_plasma_membrane | 0.67213842 |
| 158 | MP0002160_abnormal_reproductive_system | 0.66604826 |
| 159 | MP0004233_abnormal_muscle_weight | 0.65688421 |
| 160 | MP0003045_fibrosis | 0.64466458 |
| 161 | MP0004019_abnormal_vitamin_homeostasis | 0.64175819 |
| 162 | MP0001663_abnormal_digestive_system | 0.64097052 |
| 163 | MP0003806_abnormal_nucleotide_metabolis | 0.63556595 |
| 164 | MP0001502_abnormal_circadian_rhythm | 0.63334112 |
| 165 | MP0000647_abnormal_sebaceous_gland | 0.63070800 |
| 166 | MP0004133_heterotaxia | 0.62945682 |
| 167 | MP0005195_abnormal_posterior_eye | 0.62366606 |
| 168 | MP0000026_abnormal_inner_ear | 0.61060422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.31277052 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.76413940 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.48313386 |
| 4 | Hyperventilation (HP:0002883) | 5.38504595 |
| 5 | Congenital stationary night blindness (HP:0007642) | 5.19542801 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.87375650 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.71887802 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.71887802 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.71887802 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.47217434 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.43372235 |
| 12 | Concave nail (HP:0001598) | 4.43092248 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.20657288 |
| 14 | Obstructive lung disease (HP:0006536) | 4.00492586 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.00492586 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.80845913 |
| 17 | Recurrent skin infections (HP:0001581) | 3.78501025 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.58395725 |
| 19 | Axonal loss (HP:0003447) | 3.56336495 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.49065759 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.49065759 |
| 22 | Pancreatic cysts (HP:0001737) | 3.48074002 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.42644635 |
| 24 | Disinhibition (HP:0000734) | 3.37782994 |
| 25 | Agnosia (HP:0010524) | 3.35046950 |
| 26 | Gingivitis (HP:0000230) | 3.30270762 |
| 27 | Attenuation of retinal blood vessels (HP:0007843) | 3.22198736 |
| 28 | Severe visual impairment (HP:0001141) | 3.21124661 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.20786507 |
| 30 | Abnormality of macular pigmentation (HP:0008002) | 3.10286965 |
| 31 | Protruding tongue (HP:0010808) | 3.06191126 |
| 32 | Focal motor seizures (HP:0011153) | 3.04303575 |
| 33 | Clumsiness (HP:0002312) | 3.01565248 |
| 34 | Dysostosis multiplex (HP:0000943) | 3.00808643 |
| 35 | Stomatitis (HP:0010280) | 2.95950787 |
| 36 | True hermaphroditism (HP:0010459) | 2.94618603 |
| 37 | Optic neuritis (HP:0100653) | 2.90574330 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.90574330 |
| 39 | Amelogenesis imperfecta (HP:0000705) | 2.89521856 |
| 40 | Albinism (HP:0001022) | 2.87208153 |
| 41 | Prostate neoplasm (HP:0100787) | 2.85318497 |
| 42 | Molar tooth sign on MRI (HP:0002419) | 2.80886275 |
| 43 | Abnormality of midbrain morphology (HP:0002418) | 2.80886275 |
| 44 | Nephronophthisis (HP:0000090) | 2.80686300 |
| 45 | Absent speech (HP:0001344) | 2.79830966 |
| 46 | Type II lissencephaly (HP:0007260) | 2.77096143 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.76332265 |
| 48 | Absent frontal sinuses (HP:0002688) | 2.75992695 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.75652796 |
| 50 | Glomerulonephritis (HP:0000099) | 2.74262489 |
| 51 | Myositis (HP:0100614) | 2.69289043 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65333319 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65333319 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65333319 |
| 55 | Abnormality of the renal medulla (HP:0100957) | 2.64503985 |
| 56 | Mutism (HP:0002300) | 2.58556493 |
| 57 | J-shaped sella turcica (HP:0002680) | 2.58344306 |
| 58 | Congenital sensorineural hearing impairment (HP:0008527) | 2.56532212 |
| 59 | Inappropriate behavior (HP:0000719) | 2.55151904 |
| 60 | Diplopia (HP:0000651) | 2.54644836 |
| 61 | Abnormality of binocular vision (HP:0011514) | 2.54644836 |
| 62 | Abnormal ciliary motility (HP:0012262) | 2.53458351 |
| 63 | Orchitis (HP:0100796) | 2.51527344 |
| 64 | Meningitis (HP:0001287) | 2.50551846 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.50104441 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.50104441 |
| 67 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47884963 |
| 68 | Medial flaring of the eyebrow (HP:0010747) | 2.47448575 |
| 69 | Widely spaced teeth (HP:0000687) | 2.44812625 |
| 70 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.42073873 |
| 71 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.41211623 |
| 72 | Neonatal respiratory distress (HP:0002643) | 2.40964879 |
| 73 | Progressive cerebellar ataxia (HP:0002073) | 2.39423896 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.38859163 |
| 75 | Hemiparesis (HP:0001269) | 2.38176411 |
| 76 | Tubular atrophy (HP:0000092) | 2.37494046 |
| 77 | Polydipsia (HP:0001959) | 2.33809756 |
| 78 | Abnormal drinking behavior (HP:0030082) | 2.33809756 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28605698 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.27285801 |
| 81 | Apathy (HP:0000741) | 2.26791908 |
| 82 | Vasculitis (HP:0002633) | 2.26448538 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.26150360 |
| 84 | IgM deficiency (HP:0002850) | 2.24309902 |
| 85 | Abnormality of the renal cortex (HP:0011035) | 2.23335047 |
| 86 | Recurrent viral infections (HP:0004429) | 2.23160016 |
| 87 | Recurrent pneumonia (HP:0006532) | 2.22547282 |
| 88 | Ketosis (HP:0001946) | 2.21984877 |
| 89 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.20466087 |
| 90 | Focal seizures (HP:0007359) | 2.20260228 |
| 91 | Neurofibrillary tangles (HP:0002185) | 2.19980339 |
| 92 | Large for gestational age (HP:0001520) | 2.19016642 |
| 93 | Breast carcinoma (HP:0003002) | 2.18569481 |
| 94 | Loss of speech (HP:0002371) | 2.18058798 |
| 95 | Colitis (HP:0002583) | 2.17167090 |
| 96 | Metaphyseal dysplasia (HP:0100255) | 2.15585029 |
| 97 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.14295154 |
| 98 | Diminished motivation (HP:0000745) | 2.14218323 |
| 99 | Cellulitis (HP:0100658) | 2.13675317 |
| 100 | Gait imbalance (HP:0002141) | 2.12268188 |
| 101 | Cystic liver disease (HP:0006706) | 2.09738518 |
| 102 | Inability to walk (HP:0002540) | 2.08661607 |
| 103 | Cheilitis (HP:0100825) | 2.08104659 |
| 104 | Febrile seizures (HP:0002373) | 2.07957405 |
| 105 | Gaze-evoked nystagmus (HP:0000640) | 2.06180276 |
| 106 | Chronic otitis media (HP:0000389) | 2.05154879 |
| 107 | Abolished electroretinogram (ERG) (HP:0000550) | 2.05128826 |
| 108 | Abnormality of dental color (HP:0011073) | 2.04807500 |
| 109 | Inflammation of the large intestine (HP:0002037) | 2.04527117 |
| 110 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01317259 |
| 111 | Cerebellar dysplasia (HP:0007033) | 2.00090965 |
| 112 | Osteomyelitis (HP:0002754) | 1.99706519 |
| 113 | Pulmonary infiltrates (HP:0002113) | 1.99489064 |
| 114 | Visual hallucinations (HP:0002367) | 1.97887281 |
| 115 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.97316636 |
| 116 | Mesangial abnormality (HP:0001966) | 1.96257808 |
| 117 | Congenital primary aphakia (HP:0007707) | 1.95961818 |
| 118 | Ketoacidosis (HP:0001993) | 1.95774354 |
| 119 | Generalized hypopigmentation (HP:0007513) | 1.94072401 |
| 120 | Thoracic kyphosis (HP:0002942) | 1.93635623 |
| 121 | Short 1st metacarpal (HP:0010034) | 1.91685701 |
| 122 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.91685701 |
| 123 | Polyuria (HP:0000103) | 1.90792037 |
| 124 | Congenital hepatic fibrosis (HP:0002612) | 1.90402461 |
| 125 | Spontaneous hematomas (HP:0007420) | 1.90244081 |
| 126 | Type I diabetes mellitus (HP:0100651) | 1.89384526 |
| 127 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.89086286 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.89008701 |
| 129 | Hemoptysis (HP:0002105) | 1.87963773 |
| 130 | Abnormality of the pons (HP:0007361) | 1.85219059 |
| 131 | Urticaria (HP:0001025) | 1.84913473 |
| 132 | Pendular nystagmus (HP:0012043) | 1.84717083 |
| 133 | Pachygyria (HP:0001302) | 1.84229768 |
| 134 | Hypoplasia of the pons (HP:0012110) | 1.83937442 |
| 135 | Basal ganglia calcification (HP:0002135) | 1.83331143 |
| 136 | Upper limb muscle weakness (HP:0003484) | 1.82878845 |
| 137 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81884544 |
| 138 | Myocardial infarction (HP:0001658) | 1.81697290 |
| 139 | Genetic anticipation (HP:0003743) | 1.81145932 |
| 140 | Abnormality of the frontal sinuses (HP:0002687) | 1.80997074 |
| 141 | Stomach cancer (HP:0012126) | 1.80252548 |
| 142 | Tetany (HP:0001281) | 1.79909211 |
| 143 | Epiphyseal dysplasia (HP:0002656) | 1.79796082 |
| 144 | Intellectual disability, progressive (HP:0006887) | 1.79772079 |
| 145 | Poor head control (HP:0002421) | 1.78575127 |
| 146 | Gastrointestinal inflammation (HP:0004386) | 1.77881392 |
| 147 | Deformed sella turcica (HP:0002681) | 1.77059537 |
| 148 | Spondylolisthesis (HP:0003302) | 1.76451711 |
| 149 | Peripheral demyelination (HP:0011096) | 1.75524016 |
| 150 | Submucous cleft hard palate (HP:0000176) | 1.74979707 |
| 151 | Ocular albinism (HP:0001107) | 1.74762902 |
| 152 | Furrowed tongue (HP:0000221) | 1.73920832 |
| 153 | Leukocytosis (HP:0001974) | 1.73402691 |
| 154 | Macroglossia (HP:0000158) | 1.72213547 |
| 155 | Lower limb amyotrophy (HP:0007210) | 1.71928294 |
| 156 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.71877105 |
| 157 | Bile duct proliferation (HP:0001408) | 1.71455450 |
| 158 | Abnormal biliary tract physiology (HP:0012439) | 1.71455450 |
| 159 | Joint hemorrhage (HP:0005261) | 1.71313033 |
| 160 | Thick nail (HP:0001805) | 1.70832606 |
| 161 | Tongue fasciculations (HP:0001308) | 1.70674991 |
| 162 | Obstructive sleep apnea (HP:0002870) | 1.69927257 |
| 163 | Progressive inability to walk (HP:0002505) | 1.69830830 |
| 164 | Abnormality of the sella turcica (HP:0002679) | 1.69708827 |
| 165 | Genital tract atresia (HP:0001827) | 1.69339812 |
| 166 | Parakeratosis (HP:0001036) | 1.69095519 |
| 167 | Periodontitis (HP:0000704) | 1.68621785 |
| 168 | Disproportionate short-trunk short stature (HP:0003521) | 1.68403295 |
| 169 | Agammaglobulinemia (HP:0004432) | 1.68189963 |
| 170 | Dialeptic seizures (HP:0011146) | 1.67783446 |
| 171 | Cerebral inclusion bodies (HP:0100314) | 1.67487316 |
| 172 | Dementia (HP:0000726) | 1.67398506 |
| 173 | Distal lower limb amyotrophy (HP:0008944) | 1.67386436 |
| 174 | Lissencephaly (HP:0001339) | 1.66971697 |
| 175 | Broad-based gait (HP:0002136) | 1.66368888 |
| 176 | EEG with generalized epileptiform discharges (HP:0011198) | 1.65560152 |
| 177 | Generalized hypopigmentation of hair (HP:0011358) | 1.65500932 |
| 178 | Decreased central vision (HP:0007663) | 1.64710618 |
| 179 | Nephrogenic diabetes insipidus (HP:0009806) | 1.63567354 |
| 180 | Meningioma (HP:0002858) | 1.62478794 |
| 181 | Abnormality of the femoral head (HP:0003368) | 1.61782482 |
| 182 | Infertility (HP:0000789) | 1.61681183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.22342381 |
| 2 | RIPK4 | 4.73494507 |
| 3 | TESK2 | 4.02170411 |
| 4 | IRAK4 | 3.55702502 |
| 5 | FES | 3.42576835 |
| 6 | MAP4K1 | 3.38935448 |
| 7 | MUSK | 3.32147788 |
| 8 | PINK1 | 3.15922244 |
| 9 | MAPKAPK3 | 3.01741806 |
| 10 | MAP4K2 | 3.01193875 |
| 11 | CASK | 2.78555994 |
| 12 | SIK2 | 2.74494884 |
| 13 | EPHA4 | 2.63103921 |
| 14 | MAP3K14 | 2.50635343 |
| 15 | IRAK3 | 2.32393470 |
| 16 | BLK | 2.30395692 |
| 17 | ACVR1B | 2.19487675 |
| 18 | SIK3 | 2.16843124 |
| 19 | MAP3K13 | 2.02048447 |
| 20 | INSRR | 1.95794218 |
| 21 | KIT | 1.84938593 |
| 22 | TGFBR2 | 1.82138621 |
| 23 | TBK1 | 1.81585981 |
| 24 | GRK7 | 1.78586106 |
| 25 | NTRK3 | 1.78339508 |
| 26 | FGR | 1.76155370 |
| 27 | WNK3 | 1.68324817 |
| 28 | MAPK13 | 1.63237833 |
| 29 | ZAK | 1.59838017 |
| 30 | STK38L | 1.59559815 |
| 31 | CSF1R | 1.58126121 |
| 32 | LATS1 | 1.50883440 |
| 33 | BMPR2 | 1.49079137 |
| 34 | JAK3 | 1.48940631 |
| 35 | SYK | 1.46687263 |
| 36 | TRIM28 | 1.44243753 |
| 37 | HCK | 1.40360126 |
| 38 | TXK | 1.39196350 |
| 39 | IKBKB | 1.39184452 |
| 40 | TNIK | 1.38064607 |
| 41 | IKBKE | 1.37905188 |
| 42 | TYK2 | 1.25724876 |
| 43 | CAMK1G | 1.22367254 |
| 44 | BMPR1B | 1.21959685 |
| 45 | IRAK2 | 1.20183004 |
| 46 | ADRBK2 | 1.18445693 |
| 47 | RPS6KB2 | 1.16792848 |
| 48 | CSK | 1.16650579 |
| 49 | YES1 | 1.15361815 |
| 50 | LYN | 1.14135126 |
| 51 | TEC | 1.13348051 |
| 52 | EIF2AK3 | 1.12955105 |
| 53 | CLK1 | 1.11692391 |
| 54 | PIK3CA | 1.10678313 |
| 55 | EPHB1 | 1.09900620 |
| 56 | AKT3 | 1.09387352 |
| 57 | CAMK1D | 1.08834489 |
| 58 | DAPK2 | 1.03626022 |
| 59 | STK38 | 1.03050103 |
| 60 | LCK | 1.00377322 |
| 61 | MAP2K7 | 0.99820963 |
| 62 | FER | 0.96786855 |
| 63 | PRKD2 | 0.95700008 |
| 64 | NTRK2 | 0.95688653 |
| 65 | JAK1 | 0.95412355 |
| 66 | NUAK1 | 0.94078790 |
| 67 | TLK1 | 0.93746182 |
| 68 | BTK | 0.92937196 |
| 69 | MARK3 | 0.90268276 |
| 70 | MAP2K2 | 0.89826990 |
| 71 | ADRBK1 | 0.83146489 |
| 72 | MAP2K1 | 0.83093813 |
| 73 | PLK2 | 0.82680011 |
| 74 | PNCK | 0.82598985 |
| 75 | PKN2 | 0.81992235 |
| 76 | CAMKK1 | 0.80298700 |
| 77 | PRKCQ | 0.79869115 |
| 78 | IRAK1 | 0.79838731 |
| 79 | MAP3K9 | 0.78374581 |
| 80 | MAP3K4 | 0.77921744 |
| 81 | MAPK15 | 0.77768734 |
| 82 | MAP2K6 | 0.76421978 |
| 83 | NEK6 | 0.76237519 |
| 84 | GRK1 | 0.73156444 |
| 85 | MAP3K12 | 0.71917209 |
| 86 | TNK2 | 0.71330548 |
| 87 | PDK1 | 0.71124334 |
| 88 | EPHA3 | 0.69014420 |
| 89 | ZAP70 | 0.68651788 |
| 90 | PKN1 | 0.68321869 |
| 91 | ABL2 | 0.68309552 |
| 92 | DMPK | 0.68148558 |
| 93 | MYLK | 0.67194658 |
| 94 | CAMK2D | 0.65471896 |
| 95 | PTK2B | 0.64945617 |
| 96 | PRKCI | 0.64357944 |
| 97 | ITK | 0.64200628 |
| 98 | SGK2 | 0.63856559 |
| 99 | PDPK1 | 0.63833331 |
| 100 | JAK2 | 0.63542982 |
| 101 | PRKCZ | 0.63094877 |
| 102 | CAMK2B | 0.62647708 |
| 103 | PHKG1 | 0.62012346 |
| 104 | PHKG2 | 0.62012346 |
| 105 | PRKD3 | 0.61634030 |
| 106 | GRK5 | 0.60104880 |
| 107 | NTRK1 | 0.59789344 |
| 108 | FYN | 0.59542579 |
| 109 | TAOK1 | 0.59092729 |
| 110 | PRPF4B | 0.58905726 |
| 111 | CAMK2G | 0.58266502 |
| 112 | RPS6KA2 | 0.57439212 |
| 113 | TAOK3 | 0.57091870 |
| 114 | DAPK1 | 0.56627692 |
| 115 | CAMKK2 | 0.55763757 |
| 116 | ABL1 | 0.55303581 |
| 117 | PRKCD | 0.52723301 |
| 118 | CDK5 | 0.52247144 |
| 119 | PRKAA2 | 0.52236238 |
| 120 | SGK494 | 0.52155844 |
| 121 | SGK223 | 0.52155844 |
| 122 | CSNK1A1 | 0.52130716 |
| 123 | PAK3 | 0.51439498 |
| 124 | CAMK2A | 0.51327024 |
| 125 | PDGFRB | 0.51110273 |
| 126 | TAOK2 | 0.50875639 |
| 127 | STK3 | 0.49639370 |
| 128 | GRK6 | 0.49291906 |
| 129 | MAPK7 | 0.48680093 |
| 130 | CHUK | 0.48426410 |
| 131 | CSNK1A1L | 0.48138757 |
| 132 | SGK1 | 0.47557015 |
| 133 | MINK1 | 0.46920449 |
| 134 | MAPK12 | 0.46255398 |
| 135 | TAF1 | 0.45965819 |
| 136 | PRKCG | 0.45877173 |
| 137 | EGFR | 0.45533550 |
| 138 | CSNK1D | 0.44821176 |
| 139 | EIF2AK2 | 0.44626035 |
| 140 | MOS | 0.44023666 |
| 141 | STK11 | 0.40917107 |
| 142 | DYRK1A | 0.39628847 |
| 143 | LIMK1 | 0.39627035 |
| 144 | MST4 | 0.39531271 |
| 145 | INSR | 0.38714014 |
| 146 | NME1 | 0.38062001 |
| 147 | CAMK1 | 0.37919880 |
| 148 | WNK4 | 0.37852973 |
| 149 | PRKCE | 0.37113688 |
| 150 | PRKD1 | 0.35733979 |
| 151 | MARK1 | 0.35307872 |
| 152 | MAP3K1 | 0.35228060 |
| 153 | MAPK8 | 0.34842906 |
| 154 | MATK | 0.34594530 |
| 155 | ERBB2 | 0.34130562 |
| 156 | NEK9 | 0.33862382 |
| 157 | KSR1 | 0.33784596 |
| 158 | CSNK1G3 | 0.32114543 |
| 159 | TGFBR1 | 0.31678935 |
| 160 | RIPK1 | 0.31508320 |
| 161 | SRC | 0.31266472 |
| 162 | TESK1 | 0.31154590 |
| 163 | RPS6KA6 | 0.28917185 |
| 164 | RPS6KB1 | 0.27784445 |
| 165 | DYRK2 | 0.26415293 |
| 166 | CSNK1G2 | 0.26315820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 2.68864805 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.53114741 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.38792636 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.24733473 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22796631 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.19751084 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.12797218 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.10453887 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.08789371 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.01152327 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.97605203 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93511046 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 1.91525452 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.84802273 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.83402314 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.77036375 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.74208999 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74040008 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.72780271 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66955911 |
| 21 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.64817373 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.63442995 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60089439 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57340964 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56855680 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53694606 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51433321 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49935223 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49925972 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.47919502 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42063892 |
| 32 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.39809772 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.39807790 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.34352526 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.33692467 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.33273721 |
| 37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.30207482 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26568115 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26233417 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.23875639 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22016090 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.20872405 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.17028211 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.16976809 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16552819 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.15378739 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.12896376 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11115515 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10220600 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09631003 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.09154310 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07668420 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 1.07001801 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06955349 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06813921 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06695701 |
| 57 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.06457637 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.06356927 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.05111207 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 1.01891514 |
| 61 | Asthma_Homo sapiens_hsa05310 | 1.01122012 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01049227 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.97985866 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97409371 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.96653841 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96152321 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.95676037 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95597060 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94876564 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94714299 |
| 71 | Taste transduction_Homo sapiens_hsa04742 | 0.94521477 |
| 72 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94484637 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.93086470 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92891637 |
| 75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.92608933 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.90341430 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90194865 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89677853 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87444739 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.87085328 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86983782 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86914425 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84517511 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84073021 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83947206 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.82973985 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81728717 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81046155 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80539767 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80528512 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79970991 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79403376 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.79150625 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78835686 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.78098935 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77553577 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75968234 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75900099 |
| 99 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75367805 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74853668 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74511176 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.72933381 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72543904 |
| 104 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72402326 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71488759 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71158391 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70569544 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69801389 |
| 109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68598958 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67619646 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67228372 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66654899 |
| 113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66229189 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.65875383 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64328664 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63435796 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63172688 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62829060 |
| 119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62716001 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.62583810 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62574303 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61435859 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61271138 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61084031 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60973350 |
| 126 | Hepatitis B_Homo sapiens_hsa05161 | 0.60551241 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60112182 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59553189 |
| 129 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57761032 |
| 130 | Legionellosis_Homo sapiens_hsa05134 | 0.57674695 |
| 131 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57366382 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56669825 |
| 133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56060600 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.53353302 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53002051 |
| 136 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52580350 |
| 137 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52533961 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52381488 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52140937 |
| 140 | Homologous recombination_Homo sapiens_hsa03440 | 0.49272744 |
| 141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46951570 |
| 142 | Insulin resistance_Homo sapiens_hsa04931 | 0.43763959 |
| 143 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39973551 |
| 144 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36794222 |
| 145 | Bladder cancer_Homo sapiens_hsa05219 | 0.34397923 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32841300 |

